MedTrace Logo

Peptide Profiles of Women Undergoing Breast Biopsy

NCT00587821 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 571

Last updated 2013-12-19

No results posted yet for this study

Summary

This study is being done to learn about blood proteins. We want to see if the blood proteins in women whose biopsies show breast cancer are different from the blood proteins in women whose biopsies do not show breast cancer. The goal of this study is to develop a blood test than can help detect breast cancers when they are very small and easy to cure.

Conditions

Interventions

OTHER

Blood draw

Peptide profiles from blood samples of all subjects will be determined by mass spectrometric analysis.

Sponsors & Collaborators

Principal Investigators

  • Mark Robson, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00587821 on ClinicalTrials.gov